Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants

Stock Track05-05

Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.

The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.

Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156798443?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156798443","market":"nz","top_or_hot":-1,"title":"Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants","media":"Stock Track","content":"<p>Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.</p><p>The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.</p><p>Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-05 21:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.</p><p>The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.</p><p>Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1156798443","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156798443","pubTimestamp":1777988697,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.The surge comes after multiple investment firms upgraded their...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"个股追踪|Twist Bioscience因分析师升级和新员工股权授予盘中飙升5.87%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156798443","isCrawlerRequest":true}